In a multicenter study aimed at assessing the diagnostic utility of CSF YKL-40 in differentiating clinical Alzheimer’s disease from other neurodegenerative diseases, the biomarker discriminated Alzheimer’s disease from frontotemporal dementia [195]. The gene discussed is CHI3L1; the disease is early-onset autosomal dominant Alzheimer disease.